American Journal of Cardiology
Volume 102, Issue 9 , Pages 1119-1124 , 1 November 2008

Relation Between Previous Lipid-Lowering Therapy and Infarct Size (Creatine Kinase-MB Level) in Patients Presenting With Acute Myocardial Infarction

  • Herbert D. Aronow, MD, MPH

      Affiliations

    • Clinical Scholars Program, Michigan Heart and Vascular Institute at St. Joseph Mercy Hospital, Ann Arbor, Michigan
    • Corresponding Author InformationCorresponding author: Tel: 734-712-8000; Fax: 734-712-8010
    • ,
  • A. Michael Lincoff, MD

      Affiliations

    • Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Martin J. Quinn, MD, PhD

      Affiliations

    • St. Vincents University Hospital, Dublin, Ireland
    • ,
  • A. Thomas McRae, MD

      Affiliations

    • Centennial Heart Cardiovascular Consultants, Nashville, Tennessee
    • ,
  • Hitinder S. Gurm, MD

      Affiliations

    • Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan
    • ,
  • Penny L. Houghtaling, MS

      Affiliations

    • Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Franz Van de Werf, MD, PhD

      Affiliations

    • Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Eric J. Topol, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
    • ,
  • Michael S. Lauer, MD

      Affiliations

    • Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • GUSTO IIb and PURSUIT Trial Investigators

Received 27 February 2008 ,Revised 17 June 2008 ,Accepted 17 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) was supported by COR Therapeutics, Inc., San Francisco, California, and Schering-Plough Research Institute, Kenilworth, New Jersey; and Global Use of Streptokinase or t-PA for Occluded Coronary Arteries IIb (GUSTO IIb) was supported by Ciba-Geigy, Inc., Summit, New Jersey; Boehringer-Mannheim, Indianapolis, Indiana; and Guidant Corp., Redwood City, California.

PII: S0002-9149(08)01134-X

doi: 10.1016/j.amjcard.2008.06.032

American Journal of Cardiology
Volume 102, Issue 9 , Pages 1119-1124 , 1 November 2008

Article Tools

* Image Usage & Resolution